Physician profile
John P Richards
NPI 1588627970
$4,227.30
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $968 · 2020: $780 · 2021: $973 · 2022: $729 · 2023: $755 · 2024: $23.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $739.81 | 2019-2024 | |
| Glaxosmithkline, LLC. | $516.77 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $496.30 | 2019-2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $436.23 | 2019-2023 | Breztri, Farxiga |
| Abbvie INC. | $357.84 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $311.37 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $247.42 | 2019-2022 | |
| Novo Nordisk INC | $224.80 | 2019-2023 | Ozempic |
| Allergan, INC. | $191.24 | 2019-2020 | |
| Amarin Pharma, INC. | $149.54 | 2019-2021 | |
| Lilly USA, LLC | $106.31 | 2019-2021 | |
| Exact Sciences Corporation | $75.78 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.64 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $68.08 | 2019-2023 | |
| Redhill Biopharma INC. | $64.86 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $35.57 | 2022 | |
| Xeris Pharmaceuticals, INC. | $31.69 | 2021-2023 | Gvoke Hypopen |
| Becton, Dickinson and Company | $31.32 | 2022 | |
| Biogen, INC. | $22.36 | 2021 | |
| Dexcom, INC. | $20.74 | 2021 | |
| Shire North American Group INC | $13.51 | 2019 | |
| Eisai INC. | $11.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.